Furthermore, L-4F led to down-regulation of IL-17A and IL-4 (Figure 3), suggesting that, in addition to its direct anti-inflammatory effect, L-4F can change the phenotypes of TAMs in pancreatic tumors by altering the microenvironment. Here, IL17A is linked to pancreatic neoplasm.